Adherence counseling during patient contacts in Swiss community pharmacies
Patient Preference and Adherence
Dovepress
open access to scientific and medical research
Original Research
Patient Preference and Adherence downloaded from https://www.dovepress.com/ by 54.38.22.117 on 13-Jul-2018
For personal use only.
Open Access Full Text Article
Adherence counseling during patient contacts
in Swiss community pharmacies
This article was published in the following Dove Press journal:
Patient Preference and Adherence
24 April 2015
Number of times this article has been viewed
Fabienne Boeni
Isabelle Arnet
Kurt E Hersberger
Pharmaceutical Care Research Group,
Department of Pharmaceutical
Sciences, University of Basel, Basel,
Switzerland
Purpose: Numerous studies showed the effectiveness of pharmaceutical care in improving
medication adherence in primary care patients. However, in daily pharmacy practice, the provision of pharmaceutical care appears to be limited. We aimed at quantifying the content of counseling by community pharmacy staff during patient contacts, especially adherence counseling,
and at investigating pharmacist views about their practice of adherence counseling.
Patients and methods: A Master’s student in Pharmacy observed patient contacts at selected
community pharmacies in the region of Basel, Switzerland. Content of counseling was manually ticked on a checklist with predefined themes (administration, dose, effect, and adherence).
Pharmacists working in the pharmacy were interviewed on triggers, topics, and barriers in
adherence counseling.
Results: In 20 community pharmacies and during a total of 148.1 hours, 1,866 patient contacts
were observed. During the 1,476 patient contacts including the dispensing of one or more medications, counseling was provided to 799 (54.1%) patients; with 735 (49.8%) patients counseled
about administration, 362 (24.5%) about dose, 267 (18.1%) about effect, and 99 (6.7%) about
adherence. Significantly more patients received counseling when they obtained prescribed
versus over-the-counter medication (P=0.002), a new prescription versus a repeat prescription
(P0.001), or when they were served by a pharmacist versus by another staff member (P0.001).
Of the 33 interviewed pharmacists, all except one reported actively approaching patients for
adherence counseling. Triggers included medication-related and patient-related factors. The
pharmacists named predominantly product-centered topics of adherence counseling. The most
cited barriers were rejection of counseling by the patient and lack of time.
Conclusion: Half of the patients receiving one or more medications were counseled, and only
6.7% of all contacts included adherence counseling. Future studies should clarify how barriers
to adherence counseling at the community pharmacy can be overcome.
Keywords: pharmaceutical care, community pharmacy, medication adherence
Introduction
Correspondence: Fabienne Boeni
Pharmaceutical Care Research Group,
Department of Pharmaceutical Sciences,
University of Basel, Klingelbergstrasse 50,
CH-4056 Basel, Switzerland
Tel +41 61 267 15 29
Fax +41 61 267 14 26
Email
597
submit your manuscript | www.dovepress.com
Patient Preference and Adherence 2015:9 597–605
Dovepress
© 2015 Boeni et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on
how to request permission may be found at: http://www.dovepress.com/permissions.php
http://dx.doi.org/10.2147/PPA.S76027
Powered by TCPDF (www.tcpdf.org)
Pharmaceutical care has been defined as “…the pharmacist’s contribution to the care
of individuals in order to optimize medicines use and improve health outcomes,”1 and
the pharmacist has been designated as part of the health care team for added value
in the health care system.2–4 Pharmaceutical care activities practiced by community
pharmacies have been shown effective in improving medication adherence.5–12 Faceto-face counseling during dispensing of medication is part of pharmaceutical care.4
Counseling can include providing education to patients (eg, about therapy, their
condition), intervening in a patient’s drug therapy (eg, optimizing intake times),
and ultimately, helping improve medication adherence.13 Previous studies reported
significantly improved adherence and persistence through targeted counseling by
community pharmacists.14–16
Dovepress
Patient Preference and Adherence downloaded from https://www.dovepress.com/ by 54.38.22.117 on 13-Jul-2018
For personal use only.
Boeni et al
Counseling practice in community pharmacies has
been reported to be limited. In a pan-Europe comparison
in 2009, the mean total score of pharmaceutical care provision, expressed as a percentage of the total score achievable, ranged from 31.6% to 52.2%.17 Patient counseling
was reported to be only a minor task in every day practice
in the community pharmacy,18–21 and communication was
predominantly nonmedical or product-centered, instead of
patient-centered.22–24
At the dispensing of prescription medication, Swiss
pharmacists are reimbursed for providing counseling on
dose, frequency, administration, duration of use, storage,
and potential adverse effects.25 Introduced in 2005, this was
the first acknowledgment of cognitive services delivered
by community pharmacists to improve the patients’ use of
medication. Additionally, the provision of a dose-dispensing
aid by the pharmacy is reimbursed.26
To our knowledge, the current counseling practices in
Swiss community pharmacies have not yet been addressed,
especially the content of adherence counseling. The aim
of this study was to quantify the content of counseling by
community pharmacy staff during patient contacts, with a
specific focus on adherence counseling, and to investigate
the views of community pharmacists about their practice of
adherence counseling.
Material and methods
Of 106 community pharmacies in the region of Basel,
Switzerland, community pharmacies that had participated in
previous studies27,28 were approached consecutively, according to a random number list, until the sample size of 20 was
reached. This number was calculated to enable approximately
2,000 patient contacts, assuming that counseling would take 5
minutes and one investigator could observe approximately 100
patients during 8 hours. We did not perform analysis of health
communication between pharmacy staff and patients, but
rather, we observed and quantified the content of counseling.
A Master’s student in Pharmacy observed the patient contacts
of the pharmacy staff in sequential order during 1 day at each
pharmacy. The observation began at the entrance of one pat (...truncated)